NCT06126770 is a NA clinical trial of The social norm intervention in Sexual and Reproductive Health and Rights, sponsored by International Centre for Diarrhoeal Disease Research, Bangladesh.

Who is sponsoring NCT06126770?

NCT06126770 is sponsored by International Centre for Diarrhoeal Disease Research, Bangladesh.

What drugs are being tested in NCT06126770?

Interventions in NCT06126770: The social norm intervention.

What condition does NCT06126770 study?

NCT06126770 studies Sexual and Reproductive Health and Rights.

Is NCT06126770 still recruiting?

NCT06126770 is currently status unknown. Last updated 18 November 2023.

Last reviewed 2023-11-18 · How we verify

NCT06126770

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Development and Testing of Balika Bodhu

Status unknown NA Last updated 18 November 2023

What this trial tests

NA trial testing The social norm intervention in Sexual and Reproductive Health and Rights in 2,918 participants. Status unknown.

Timeline

8 November 2023

Primary endpoint
28 February 2025

31 March 2025

Quick facts

Lead sponsor	International Centre for Diarrhoeal Disease Research, Bangladesh
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	prevention
Enrollment	2,918
Start date	8 November 2023
Primary completion	28 February 2025
Estimated completion	31 March 2025
Sites	1 location across Bangladesh

Drugs / interventions tested

The social norm intervention

Conditions studied

Sexual and Reproductive Health and Rights — all drugs for Sexual and Reproductive Health and Rights →

Sponsor

International Centre for Diarrhoeal Disease Research, Bangladesh — full company profile →

Who can join

Adults 15 to 19, any sex, with Sexual and Reproductive Health and Rights. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study aims to generate knowledge on barriers experienced by married adolescent girls (MAGs) in demanding, accessing and practicing their rights regarding their sexual and reproductive health (SRH), including family planning (FP) use, conception, and seeking health care relating to SRH. We will also explore the underlying factors influencing such barriers. The study will develop and test a social norms intervention that addresses the gaps in programming and in the literature combining a comprehensive empowerment programme for MAGs with engagement of other stakeholders to increase demand, access and practices of positive behaviours in relation to sexual and reproductive health and rights (SRHR) among these girls. We will collaborate with a local organization, who usually work on empowerment and SRHR of women, for implementing the intervention and will build their capacity as well. The study will employ a mixed-method two-arm cluster randomized controlled trial design. All the information generated will inform the program and policy about the barriers and potential solutions to improve demand, access and practices of SRHR among the MAGs.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

A protocol for a cluster randomized controlled trial to assess the impact of Balika Bodhu: A combined empowerment and social norm based sexual and reproductive health and rights intervention for married adolescent girls in rural Bangladesh.
Mamun MA, Mahmud S, Antu JF, Talukder A, et al · · 2024 · PMID 39178272 · DOI 10.1371/journal.pone.0304988

Verify or expand the search:

Other International Centre for Diarrhoeal Disease Research, Bangladesh trials

Trials by the same sponsor.

NCT07537686 — Glucagon-like Peptide 2 (GLP-2) in Undernourished Women Improving From Histology-Confirmed Environmental Enteric Dysfunc · Phase 2 · not yet recruiting
NCT07345208 — Safety and Immunogenicity of ID vs IM Rabies Vaccine · Phase 2, PHASE3 · not yet recruiting
NCT07045493 — Assessing the Safety and Efficacy of a Combination Therapy for STH in PSAC in Bangladesh · Phase 2 · enrolling by invitation
NCT06757283 — ZyVac-TCV Bangladesh Study · Phase 3 · not yet recruiting
NCT06815835 — Non-interference Study of MR and Yellow Fever Vaccines Among Bangladeshi Infants Aged 9-12 Months · Phase 3 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06126770 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by International Centre for Diarrhoeal Disease Research, Bangladesh
Last refreshed: 18 November 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06126770.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing